About the Mood and Anxiety Disorders Program
Mood and anxiety disorders can affect anyone—from a young adult experiencing the first signs of bipolar disorder to a grandparent struggling with symptoms of depression. In order to advance the understanding and treatment of these challenging conditions, the Mood and Anxiety Disorders Program (MAP) at the Icahn School of Medicine at Mount Sinai combines research studies and clinical therapies into one center for scientific investigation and patient care. Under the direction of Dan Iosifescu, MD, MAP is devoted to understanding the causes of mood and anxiety disorders and developing new therapies to improve the lives of patients and families who are affected by them.
Research and Clinical Trials for Mood and Anxiety Disorders
MAP’s ongoing research studies seek to develop leading-edge treatments that include novel antidepressants, new psychotherapy strategies, and new forms of device-based therapies, such as transcranial magnetic stimulation (TMS). Our Program also conducts studies to enhance our understanding of the biology of mood and anxiety disorders by using state-of-the-art neuroimaging to investigate brain function.
We are currently conducting several research studies in mood and anxiety disorders in the following areas (all participants receive reimbursement, and all treatment studies are free of charge):
- Major depressive disorder clinical trials
- Bipolar disorder clinical trials
- Post-traumatic stress disorder (PTSD) clinical trials
Treatments for Mood and Anxiety Disorders
Many mood and anxiety disorders are treatable with a high degree of success through the use of medications, psychotherapy, and behavioral interventions. As a tertiary care referral center, MAP provides the most advanced care for patients with severe forms of treatment-resistant depression. By offering a range of comprehensive diagnostic evaluations and treatment options as well as several research protocols, MAP seeks to give our patients the therapies and support they need to experience relief from symptoms and enjoy their fullest possible function.
Atran Berg Laboratory Building
Floor E Level
1428 Madison Avenue
New York, NY 10029 Map